Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 2.41%2.62B | 5.78%1.24B | 3.90%2.56B | 10.67%1.17B | 6.68%2.46B | -11.32%1.06B | 5.67%2.31B | 8.02%1.2B | 6.30%2.18B | 6.99%1.11B |
| Operating income | 2.41%2.62B | 5.78%1.24B | 3.90%2.56B | 10.67%1.17B | 6.68%2.46B | -11.32%1.06B | 5.67%2.31B | 8.02%1.2B | 6.30%2.18B | 6.99%1.11B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Selling expenses | -1.69%-6.27M | -23.48%-3.45M | -0.70%-6.17M | 10.42%-2.79M | -21.04%-6.12M | -29.10%-3.12M | -455.21%-5.06M | -2,470.21%-2.42M | 9.71%-911K | 89.86%-94K |
| Depreciation and amortization | 1.56%-781.66M | 2.23%-390.2M | 0.17%-794.05M | -1.51%-399.08M | -1.18%-795.39M | 0.48%-393.14M | -2.68%-786.08M | -4.33%-395.03M | -13.16%-765.56M | -15.16%-378.65M |
| Impairment and provision | -100.03%-48K | -103.47%-5.95M | 2,824.25%161.3M | 2,645.26%171.25M | 99.31%-5.92M | 99.21%-6.73M | -521.72%-857.23M | -484.68%-856.49M | 9.23%-137.88M | -151.37%-146.49M |
| -Other impairment is provision | -100.03%-48K | -103.47%-5.95M | 2,824.25%161.3M | 2,645.26%171.25M | 99.31%-5.92M | 99.21%-6.73M | -521.72%-857.23M | -484.68%-856.49M | 9.23%-137.88M | -151.37%-146.49M |
| Special items of operating profit | 7.01%-140.51M | 6.39%-62.76M | -11.08%-151.11M | -20.74%-67.05M | -14.41%-136.04M | -16.41%-55.53M | 20.69%-118.91M | -3.24%-47.7M | 15.81%-149.94M | 23.90%-46.2M |
| Operating profit | -4.35%1.69B | -11.05%779.5M | 16.43%1.77B | 45.51%876.31M | 181.19%1.52B | 670.87%602.24M | -52.19%539.77M | -119.68%-105.5M | 7.91%1.13B | -8.60%535.93M |
| Financing cost | -3.64%-754.46M | -1.84%-373.92M | -10.76%-727.97M | -19.61%-367.15M | -28.80%-657.24M | -27.17%-306.96M | -4.08%-510.28M | 2.79%-241.37M | -1.46%-490.28M | -6.75%-248.3M |
| Earning before tax | -9.94%935.92M | -20.34%405.58M | 20.76%1.04B | 72.43%509.16M | 2,817.54%860.56M | 185.13%295.28M | -95.38%29.5M | -220.60%-346.87M | 13.44%638.67M | -18.69%287.62M |
| Tax | -28.56%-148.68M | -30.35%-64.07M | -19.66%-115.65M | -45.78%-49.16M | -924.32%-96.66M | -198.26%-33.72M | 87.80%-9.44M | 201.84%34.32M | -45.50%-77.35M | -10.90%-33.7M |
| After-tax profit from continuing operations | -14.76%787.25M | -25.76%341.5M | 20.90%923.59M | 75.87%460M | 3,708.09%763.9M | 183.68%261.56M | -96.43%20.06M | -223.09%-312.55M | 10.10%561.32M | -21.47%253.93M |
| Earning after tax | -14.76%787.25M | -25.76%341.5M | 20.90%923.59M | 75.87%460M | 3,708.09%763.9M | 183.68%261.56M | -96.43%20.06M | -223.09%-312.55M | 10.10%561.32M | -21.47%253.93M |
| Profit attributable to shareholders | -14.76%787.25M | -25.76%341.5M | 20.90%923.59M | 75.87%460M | 3,708.09%763.9M | 183.68%261.56M | -96.43%20.06M | -223.09%-312.55M | 10.10%561.32M | -21.47%253.93M |
| Basic earnings per share | -15.04%1.13 | -25.76%0.49 | 20.91%1.33 | 73.68%0.66 | 3,566.67%1.1 | 184.44%0.38 | -96.30%0.03 | -221.62%-0.45 | 10.96%0.81 | -21.28%0.37 |
| Diluted earnings per share | -15.04%1.13 | -25.76%0.49 | 20.91%1.33 | 73.68%0.66 | 3,566.67%1.1 | 184.44%0.38 | -96.30%0.03 | -221.62%-0.45 | 10.96%0.81 | -21.28%0.37 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.